Scott W. Morrison
Director · Tarsus Pharmaceuticals, Inc.
Individual
- 2024
- Jun 29, 2026
- 7
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Scott W. Morrison files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ying Du - $8.58M in ZLAB purchases and sales in the last 12 months
- Bobak R. Azamian - $4.69M in TARS purchases and sales in the last 12 months
- William J. Phd Link - $2.62M in TARS purchases and sales in the last 12 months
- Elizabeth Yeu Lin - $2.20M in TARS purchases and sales in the last 12 months
- Seshadri Neervannan - $2.00M in TARS purchases and sales in the last 12 months
- Jeffrey Stein - $1.65M in IDYA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Scott W. Morrison?
Scott W. Morrison is a corporate insider, tracked as Director of Tarsus Pharmaceuticals, Inc. (TARS). InsiderAlpha holds 7 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Scott W. Morrison last file a Form 4?
The most recent primary Form 4 on record is dated 29 June 2026, one of 7 filings going back to 2024.
